"Duloxetine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.
Below are MeSH descriptors whose meaning is more general than "Duloxetine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Duloxetine Hydrochloride".
This graph shows the total number of publications written about "Duloxetine Hydrochloride" by people in this website by year, and whether "Duloxetine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Duloxetine Hydrochloride" by people in Profiles.
Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators. Pain Pract. 2018 02; 18(2):154-169.
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep. 2003 Oct; 4(5):385-90.